Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2009960520;60521;60522 chr2:178591430;178591429;178591428chr2:179456157;179456156;179456155
N2AB1845855597;55598;55599 chr2:178591430;178591429;178591428chr2:179456157;179456156;179456155
N2A1753152816;52817;52818 chr2:178591430;178591429;178591428chr2:179456157;179456156;179456155
N2B1103433325;33326;33327 chr2:178591430;178591429;178591428chr2:179456157;179456156;179456155
Novex-11115933700;33701;33702 chr2:178591430;178591429;178591428chr2:179456157;179456156;179456155
Novex-21122633901;33902;33903 chr2:178591430;178591429;178591428chr2:179456157;179456156;179456155
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCT
  • RefSeq wild type template codon: GGA
  • Domain: Ig-120
  • Domain position: 20
  • Structural Position: 31
  • Q(SASA): 0.2805
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/R None None 1.0 N 0.725 0.437 0.613292534842 gnomAD-4.0.0 6.87377E-07 None None None None N None 0 0 None 0 0 None 0 0 9.01832E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.4922 ambiguous 0.4655 ambiguous -1.34 Destabilizing 1.0 D 0.671 neutral D 0.526149428 None None N
P/C 0.9572 likely_pathogenic 0.9567 pathogenic -0.951 Destabilizing 1.0 D 0.769 deleterious None None None None N
P/D 0.9492 likely_pathogenic 0.9344 pathogenic -0.943 Destabilizing 1.0 D 0.692 prob.neutral None None None None N
P/E 0.8869 likely_pathogenic 0.8691 pathogenic -0.875 Destabilizing 1.0 D 0.699 prob.neutral None None None None N
P/F 0.9705 likely_pathogenic 0.9665 pathogenic -0.786 Destabilizing 1.0 D 0.773 deleterious None None None None N
P/G 0.8858 likely_pathogenic 0.8661 pathogenic -1.719 Destabilizing 1.0 D 0.691 prob.neutral None None None None N
P/H 0.7767 likely_pathogenic 0.739 pathogenic -1.177 Destabilizing 1.0 D 0.724 prob.delet. N 0.515780505 None None N
P/I 0.9142 likely_pathogenic 0.9121 pathogenic -0.376 Destabilizing 1.0 D 0.775 deleterious None None None None N
P/K 0.9201 likely_pathogenic 0.8948 pathogenic -1.142 Destabilizing 1.0 D 0.699 prob.neutral None None None None N
P/L 0.6358 likely_pathogenic 0.6038 pathogenic -0.376 Destabilizing 1.0 D 0.749 deleterious D 0.525226708 None None N
P/M 0.917 likely_pathogenic 0.9104 pathogenic -0.416 Destabilizing 1.0 D 0.723 prob.delet. None None None None N
P/N 0.9131 likely_pathogenic 0.8936 pathogenic -1.048 Destabilizing 1.0 D 0.724 prob.delet. None None None None N
P/Q 0.7657 likely_pathogenic 0.7392 pathogenic -1.079 Destabilizing 1.0 D 0.73 prob.delet. None None None None N
P/R 0.7963 likely_pathogenic 0.7553 pathogenic -0.776 Destabilizing 1.0 D 0.725 prob.delet. N 0.50665959 None None N
P/S 0.6468 likely_pathogenic 0.6192 pathogenic -1.649 Destabilizing 1.0 D 0.712 prob.delet. N 0.503637927 None None N
P/T 0.5989 likely_pathogenic 0.5793 pathogenic -1.45 Destabilizing 1.0 D 0.699 prob.neutral N 0.482107862 None None N
P/V 0.8183 likely_pathogenic 0.8178 pathogenic -0.662 Destabilizing 1.0 D 0.672 neutral None None None None N
P/W 0.9821 likely_pathogenic 0.9791 pathogenic -1.028 Destabilizing 1.0 D 0.741 deleterious None None None None N
P/Y 0.9576 likely_pathogenic 0.9469 pathogenic -0.702 Destabilizing 1.0 D 0.783 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.